RVL Pharmaceuticals PLC (OTCPK:RVLPQ)
$ 0.0001 0 (0%) Market Cap: 11,000.00 Enterprise Value: 39.00 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q2 2019 Osmotica Pharmaceuticals PLC Earnings Call Transcript

Aug 08, 2019 / 08:30PM GMT
Release Date Price: $3.11 (-1.58%)
Operator

Good day, ladies and gentlemen, and welcome to the Osmotica Q2 2019 Earnings Conference Call. (Operator Instructions) .

I would now like to introduce your host for today's conference call, Ms. Lisa Wilson, Investor Relations of Osmotica. You may begin.

Lisa Wilson;In;Site Communications;President

Thank you, operator. Welcome to Osmotica Pharmaceuticals Second Quarter 2019 Business Update Call. This is Lisa Wilson, Investor Relations for Osmotica. With me on today's call are Osmotica's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andrew Einhorn. This afternoon, the company issued a press release detailing financial results for the 3 months ended June 30, 2019. This press release and a webcast of this call can be accessed through the Investor section of the Osmotica website at osmotica.com.

Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot